Annual Working Capital
$159.27 M
-$59.45 M-27.18%
31 December 2023
Summary:
AlloVir annual working capital is currently $159.27 million, with the most recent change of -$59.45 million (-27.18%) on 31 December 2023. During the last 3 years, it has fallen by -$189.75 million (-54.37%). ALVR annual working capital is now -54.37% below its all-time high of $349.02 million, reached on 31 December 2020.ALVR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$121.12 M
-$6.46 M-5.06%
30 September 2024
Summary:
AlloVir quarterly working capital is currently $121.12 million, with the most recent change of -$6.46 million (-5.06%) on 30 September 2024. Over the past year, it has dropped by -$65.83 million (-35.21%). ALVR quarterly working capital is now -67.30% below its all-time high of $370.42 million, reached on 30 September 2020.ALVR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.2% | -35.2% |
| 3 y3 years | -54.4% | -53.0% |
| 5 y5 years | +638.2% | - |
ALVR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.4% | at low | -53.0% | at low |
| 5 y | 5 years | -54.4% | +638.2% | -67.3% | +23.1% |
| alltime | all time | -54.4% | +638.2% | -67.3% | +23.1% |
AlloVir Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $121.12 M(-5.1%) |
| June 2024 | - | $127.58 M(-4.7%) |
| Mar 2024 | - | $133.83 M(-16.0%) |
| Dec 2023 | $159.27 M(-27.2%) | $159.27 M(-14.8%) |
| Sept 2023 | - | $186.95 M(-15.9%) |
| June 2023 | - | $222.35 M(+18.7%) |
| Mar 2023 | - | $187.32 M(-14.4%) |
| Dec 2022 | $218.71 M | $218.71 M(-13.0%) |
| Sept 2022 | - | $251.32 M(+62.2%) |
| June 2022 | - | $154.93 M(-17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $187.80 M(-12.9%) |
| Dec 2021 | $215.50 M(-38.3%) | $215.50 M(-16.4%) |
| Sept 2021 | - | $257.70 M(-12.7%) |
| June 2021 | - | $295.34 M(-8.9%) |
| Mar 2021 | - | $324.16 M(-7.1%) |
| Dec 2020 | $349.02 M(+195.3%) | $349.02 M(-5.8%) |
| Sept 2020 | - | $370.42 M(+276.5%) |
| June 2020 | - | $98.37 M(-10.3%) |
| Mar 2020 | - | $109.67 M(-7.2%) |
| Dec 2019 | $118.21 M(+447.9%) | $118.21 M |
| Dec 2018 | $21.58 M | - |
FAQ
- What is AlloVir annual working capital?
- What is the all time high annual working capital for AlloVir?
- What is AlloVir annual working capital year-on-year change?
- What is AlloVir quarterly working capital?
- What is the all time high quarterly working capital for AlloVir?
- What is AlloVir quarterly working capital year-on-year change?
What is AlloVir annual working capital?
The current annual working capital of ALVR is $159.27 M
What is the all time high annual working capital for AlloVir?
AlloVir all-time high annual working capital is $349.02 M
What is AlloVir annual working capital year-on-year change?
Over the past year, ALVR annual working capital has changed by -$59.45 M (-27.18%)
What is AlloVir quarterly working capital?
The current quarterly working capital of ALVR is $121.12 M
What is the all time high quarterly working capital for AlloVir?
AlloVir all-time high quarterly working capital is $370.42 M
What is AlloVir quarterly working capital year-on-year change?
Over the past year, ALVR quarterly working capital has changed by -$65.83 M (-35.21%)